Total Funding
16
57
Total FundingPost-IPO Equity raised
Growth Score 16 in past quarter
-33 pts
Heat Score 57 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
242676
Rixing Bio-Tech is engaged in the research and development of anthraquinone, ammonia sugar, and other fine chemical products.
About the Company
Rixing Bio-Tech is a manufacturing company that produces active pharmaceutical ingredients, including glucosamine, chondroitin sulphate, and chitosan, along with finished dosage forms such as tablets and hard capsules. Its services cover API production, formulation, and supply of bulk and finished products.